159 related articles for article (PubMed ID: 7800155)
1. Effects of long-term treatment with the MAO-A inhibitor moclobemide on sleep EEG and nocturnal hormonal secretion in normal men.
Steiger A; Benkert O; Holsboer F
Neuropsychobiology; 1994; 30(2-3):101-5. PubMed ID: 7800155
[TBL] [Abstract][Full Text] [Related]
2. Effects of trimipramine on sleep EEG, penile tumescence and nocturnal hormonal secretion. A long-term study in 3 normal controls.
Steiger A; Benkert O; Wöhrmann S; Steinseifer D; Holsboer F
Neuropsychobiology; 1989; 21(2):71-5. PubMed ID: 2515468
[TBL] [Abstract][Full Text] [Related]
3. Effects of brofaremine (CGP 11 305A), a short-acting, reversible, and selective inhibitor of MAO-A on sleep, nocturnal penile tumescence and nocturnal hormonal secretion in three healthy volunteers.
Steiger A; Holsboer F; Benkert O
Psychopharmacology (Berl); 1987; 92(1):110-4. PubMed ID: 3110820
[TBL] [Abstract][Full Text] [Related]
4. Effect of moclobemide on the psychophysiology of sleep/wake cycles: a neuroelectrophysiological study of depressed patients administered with moclobemide.
Minot R; Luthringer R; Macher JP
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):181-9. PubMed ID: 8468440
[TBL] [Abstract][Full Text] [Related]
5. The effects of moclobemide on nocturnal sleep of depressed patients.
Monti JM; Alterwain P; Monti D
J Affect Disord; 1990 Nov; 20(3):201-8. PubMed ID: 2148341
[TBL] [Abstract][Full Text] [Related]
6. Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients.
Monti JM
Br J Psychiatry Suppl; 1989 Oct; (6):61-5. PubMed ID: 2619974
[TBL] [Abstract][Full Text] [Related]
7. Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls.
von Bardeleben U; Steiger A; Gerken A; Holsboer F
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():1-5. PubMed ID: 2536765
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
Koulu M; Scheinin M; Kaarttinen A; Kallio J; Pyykkö K; Vuorinen J; Zimmer RH
Br J Clin Pharmacol; 1989 Feb; 27(2):243-55. PubMed ID: 2469451
[TBL] [Abstract][Full Text] [Related]
9. Disruption of the young-adult synchrony between luteinizing hormone release and oscillations in follicle-stimulating hormone, prolactin, and nocturnal penile tumescence (NPT) in healthy older men.
Veldhuis JD; Iranmanesh A; Mulligan T; Pincus SM
J Clin Endocrinol Metab; 1999 Oct; 84(10):3498-505. PubMed ID: 10522986
[TBL] [Abstract][Full Text] [Related]
10. Moclobemide effects on prolactin plasma levels in healthy individuals: the hormonal increase induced by a single dose is maintained during a 4-week period of drug intake.
Juruena MF; Pires ML; Calil HM
Int Clin Psychopharmacol; 1997 Nov; 12(6):317-21. PubMed ID: 9547133
[TBL] [Abstract][Full Text] [Related]
11. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression.
Sonntag A; Rothe B; Guldner J; Yassouridis A; Holsboer F; Steiger A
Depression; 1996; 4(1):1-13. PubMed ID: 9160649
[TBL] [Abstract][Full Text] [Related]
12. Effects of mianserin on human sleep.
Maeda Y; Hayashi T; Furuta H; Kim Y; Morikawa K; Ishiguro N; Ueno K; Sano J; Yamaguchi N
Neuropsychobiology; 1990-1991; 24(4):198-204. PubMed ID: 2135711
[TBL] [Abstract][Full Text] [Related]
13. Evidence that the reversible MAO-A inhibitor moclobemide increases prolactin secretion by a serotonergic mechanism in healthy male volunteers.
Scheinin M; Koulu M; Karhuvaara S; Zimmer RH
Life Sci; 1990; 47(16):1491-9. PubMed ID: 2250565
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
Burkard WP; Bonetti EP; Da Prada M; Martin JR; Polc P; Schaffner R; Scherschlicht R; Hefti F; Müller RK; Wyss PC
J Pharmacol Exp Ther; 1989 Jan; 248(1):391-9. PubMed ID: 2913284
[TBL] [Abstract][Full Text] [Related]
15. Effects of clomipramine on sleep EEG and nocturnal penile tumescence: a long-term study in a healthy man.
Steiger A
J Clin Psychopharmacol; 1988 Oct; 8(5):349-54. PubMed ID: 3183074
[TBL] [Abstract][Full Text] [Related]
16. VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men.
Murck H; Guldner J; Colla-Müller M; Frieboes RM; Schier T; Wiedemann K; Holsboer F; Steiger A
Am J Physiol; 1996 Oct; 271(4 Pt 2):R905-11. PubMed ID: 8897980
[TBL] [Abstract][Full Text] [Related]
17. Relationship between rapid eye movement sleep and testosterone secretion in normal men.
Luboshitzky R; Herer P; Levi M; Shen-Orr Z; Lavie P
J Androl; 1999; 20(6):731-7. PubMed ID: 10591612
[TBL] [Abstract][Full Text] [Related]
18. Mg2+ reduces ACTH secretion and enhances spindle power without changing delta power during sleep in men -- possible therapeutic implications.
Murck H; Steiger A
Psychopharmacology (Berl); 1998 Jun; 137(3):247-52. PubMed ID: 9683002
[TBL] [Abstract][Full Text] [Related]
19. Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.
Nair NP; Ahmed SK; Kin NM
J Psychiatry Neurosci; 1993 Nov; 18(5):214-25. PubMed ID: 7905288
[TBL] [Abstract][Full Text] [Related]
20. Effects of moclobemide on sexual performance and nocturnal erections in psychogenic erectile dysfunction.
Mann K; Pankok J; Leissner J; Benkert O
Psychopharmacology (Berl); 2001 Jun; 156(1):86-91. PubMed ID: 11465638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]